FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Kit, Dna Detection, Human Papillomavirus
PMA: P160037
·
Supplement: S022
·
Decision Aug 25, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0
Basic Information
- Device Name
- Kit, Dna Detection, Human Papillomavirus
- Trade Name
- BD ONCLARITY HPV ASSAY
- PMA Number
- P160037
- Supplement Number
- S022
- Device Class
- FDA Class 3
- Product Code
- MAQ
- Generic Name
- KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
- Medical Specialty
- Unknown
- Advisory Committee
- Microbiology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- August 25, 2025
- Date Received
- February 26, 2025
- Supplement Type
- Normal 180 Day Track No User Fee
- Supplement Reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
Approval for a manufacturing site located at Becton, Dickinson and Company, at 7 Loveton Circle, Sparks, MD, 21152, USA, for the manufacturing of the BD COR PX instrument.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| MAQ | Kit, Dna Detection, Human Papillomavirus | FDA class 3 | Unknown |